Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $19
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $11 to $19.
Citizens analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $11 to $19.